Dying to remember
Listen now
Description
Researchers at the Miller School of Medicine are testing a new drug for dementia with Lewy bodies, a disease that affects an estimated 1.4 million Americans. James Galvin, M.D., M.P.H., director of the Comprehensive Center for Brain Health at the Miller School, joins Dean Henri Ford to give insight into this devastating illness and the search for better outcomes.
More Episodes
When the very treatment keeping a patient alive also exacts a heavy toll on lives, researchers are compelled to ask, “Is there another way?”
Glioblastoma is a brutal brain cancer. It is aggressive, common and nearly always fatal. Standard treatments of radiation and chemotherapy often leave...
Published 05/22/24
Published 05/22/24
In the vast landscape of medical research, few areas are as
intricate and nuanced as traumatic brain injury. However, amidst these profound challenges lies the relentless pursuit of understanding and innovation spearheaded by pioneers like Dr. Dalton Dietrich.
Dr. Dietrich, scientific director...
Published 05/08/24
Links
Twitter
Facebook
Instagram
Patreon
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
